Who are we ?

Inovpain FHU project offers a unique opportunity to build strong and synergistic collaborations and federate clinical practice, research and teaching activities in a comprehensive program. Inovpain is centered on refractory chronic pains, but mainly focused on neuropathic pain and chronic daily headache.

 

Read more...

Work Packages

The project is structured around 6 complementary Work Packages (WP) conducted in parallel . Tight collaboration between clinicians and researchers is essential for a rapid transfer of new fundamental knowledge into clinical practice and personalized healthcare, and to stimulate research from clinical questions.

 

Read more...

The consortium

INOVPAIN is based on effective interactions between clinical teams, academic research teams and industrial partners. Several scientific and health care platforms are involved as well. Altogether, the INOVPAIN project will propose a multidisciplinary, synergistic and regionally organized network focusing on refractory chronic pains.

 

Read more...


New mechanism causing migraines discovered by FHU team member

Researchers at CNRS, Université Côte d’Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found that a genetic mutation induces dysfunction in a protein which inhibits neuronal electrical activity, causing migraines. These results, published in Neuron on December 17, 2018, open a new path for the development of anti-migraine treatments.

Read more.

Neuroscience Day - Brain Week 2019

Every year, the Brain Week is organized simultaneously in nearly 100 countries to raise general awareness of the importance of brain research and allow the general public to learn more about current research.

FHU INOVPAIN participated in this important event by organizing a special Neuroscience Day at Nice University Hospital presenting medical procédures, new therapeutics and innovations to the public.



 

Video Abstract - "Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies"

Denys Fontaine, Fabien Almairac, Serena Santucci, Charlotte Fernandez, Radhouane Dallel, Johan Pallud, Michel Lanteri-Minet

2018 Jan 29. doi: 10.1093/brain/awy005

FHU members latest publications

  1. Mallet, L, Du Montcel, ST, Clair, AH, Arbus, C, Bardinet, E, Baup, N et al.. Long-term effects of subthalamic stimulation in Obsessive-Compulsive Disorder: Follow-up of a randomized controlled trial. Brain Stimul. 2019; :. doi: 10.1016/j.brs.2019.04.004. PubMed PMID:30992192 .
  2. Humbert, O, Bourg, V, Mondot, L, Gal, J, Bondiau, PY, Fontaine, D et al.. Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions. Eur. J. Nucl. Med. Mol. Imaging. 2019; :. doi: 10.1007/s00259-019-04321-8. PubMed PMID:30980100 .
  3. Zanello, M, Meyer, B, Still, M, Goodden, JR, Colle, H, Schichor, C et al.. Surgical resection of cavernous angioma located within eloquent brain areas: International survey of the practical management among 19 specialized centers. Seizure. 2019;69 :31-40. doi: 10.1016/j.seizure.2019.03.022. PubMed PMID:30959423 .
  4. Zanello, M, Goodden, JR, Colle, H, Wager, M, Hamer, PCW, Smits, A et al.. Predictors of Epileptic Seizures and Ability to Work in Supratentorial Cavernous Angioma Located Within Eloquent Brain Areas. Neurosurgery. 2019; :. doi: 10.1093/neuros/nyz063. PubMed PMID:30924504 .
  5. Donnet, A, Emery, C, Aly, S, Allaf, B, Cayre, F, Mahieu, N et al.. Migraine burden and costs in France: a nationwide claims database analysis of triptan users. J Med Econ. 2019; :1-9. doi: 10.1080/13696998.2019.1590841. PubMed PMID:30836035 .
Search PubMed